Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pregabalin for acid-induced oesophageal pain hypersensitivity in healthy volunteers
2006-000499-33Phase 2Completed
- Sponsor
- Queen Mary University of London
- Start
- Feb 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of pregabalin in Visceral hypersensitivity (VH) and irritable bowel syndrome (IBS) (2 arms), sponsored by Queen Mary University of London. Primary endpoint: Change in upper oesophageal pain threshold post-acid infusion compared to baseline. Started Feb 2012; status: completed.
02
Drugs
pregabalin
03
Conditions
Visceral hypersensitivity (VH)irritable bowel syndrome (IBS)
Beyond the preview
Go deeper on 2006-000499-33.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-000499-33.